Q1 2026 Vivos Therapeutics Inc Earnings Call Transcript
Key Points
- Vivos Therapeutics Inc (VVOS) reported a significant 70% year-over-year increase in revenue for Q1 2026, reaching $5.1 million.
- The acquisition of the Sleep Center of Nevada (SCN) has been a key driver of revenue growth, contributing to increased diagnostic services and treatment options for OSA patients.
- Gross profit increased by 103% to $3.1 million, with a gross margin improvement from 50% to 60%, reflecting the higher-margin nature of the new business model.
- The company has successfully pivoted away from reliance on VIP enrollments, demonstrating a strategic shift towards partnering with sleep centers.
- Vivos Therapeutics Inc (VVOS) is actively pursuing affiliations with large medical specialty groups, such as cardiologists, which could significantly expand their market reach and revenue potential.
- General and administrative expenses increased significantly by $4.1 million to $9 million, primarily due to costs associated with SCN operations and additional staffing.
- The company experienced a 21% decrease in revenue from oral appliance arches and tooth positioners compared to the same period in 2025.
- Net cash used in operating activities increased to approximately $6 million for Q1 2026, indicating ongoing cash flow challenges.
- Vivos Therapeutics Inc (VVOS) will require additional financing to meet near- and long-term cash needs and to maintain NASDAQ compliance.
- The company faces challenges with dentist shortages and not being in-network with payers, impacting their ability to fully capitalize on revenue growth opportunities.
Good day, everyone, and welcome to the Vivos Therapeutics' first-quarter 2026 conference call. (Operator Instructions) This conference call is being recorded, and a replay of today's call will be available on the Investor Relations section of Vivos' website and will remain posted there for the next 30 days.
I will now hand the call over to Brad Amman, Chief Financial Officer, for introductions and the reading of the Safe Harbor statement. Please go ahead.
Thank you, operator. Hello, everyone, and welcome to our conference call. A copy of our earnings release is available on the Investor Relations section of our website at www.vivos.com. With me on the call today is Kirk Huntsman, Vivos' Chairman and Chief Executive Officer. Today, we'll review the financial results for the first quarter of 2026 as well as more recent developments and Vivos' plans for the rest of 2026 and beyond.
Following these formal remarks, we'll
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
